Astrana Health ASTH Potentially Dilutive Securities Contingently Issuable Shares

Other financials

Revenue$965.1M+55.6%

Gross profit$105.7M+48.2%

Operating income$28.5M+38.6%

Net income$14.4M+116%

EPS (diluted)$0.29+107%

Cash & equivalents$478.4M+85.0%

Total debt$1.1B+136%

Total equity$800.3M+7.4%

Total assets$2.4B+77.2%

Operating cash flow$68.1M+309%

CapEx$4.0M+30.3%

Free cash flow$64.1M+372%

Market cap$2.1B-3.0%

Gross margin10.7%-1.3pp

Operating margin2.5%-1.1pp

Net margin0.9%—

FCF margin4.6%—

Return on equity3.9%—

Debt / equity1.3×+0.7×

Current ratio1.3×-0.4×

Reported directly by Astrana Health in its filing.

Tagged under the XBRL concept asth:PotentiallyDilutiveSecuritiesContingentlyIssuableShares.

The official record: Astrana Health’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

What is Astrana Health's potentially dilutive securities contingently issuable shares?: Astrana Health (ASTH) reported potentially dilutive securities contingently issuable shares of 1.1M in Q1 2026.
How has Astrana Health's potentially dilutive securities contingently issuable shares changed year-over-year?: Astrana Health's potentially dilutive securities contingently issuable shares decreased by 4.4% year-over-year, from 1.1M to 1.1M.